by evivier@statinmed.com | Aug 30, 2022 | Cardiovascular, Publication
Abstract Introduction This study evaluated the risk of hospitalization among nonvalvular atrial fibrillation (NVAF) patients with an outpatient COVID-19 diagnosis who discontinued vs continued apixaban treatment. Methods Adult patients with...
by evivier@statinmed.com | Aug 16, 2022 | Cardiovascular, Publication
Abstract Introduction There are a paucity of real-world data examining effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial fibrillation (NVAF) patients with prior bleeding. Methods This...
by evivier@statinmed.com | Aug 16, 2022 | Infectious Disease, Publication
Abstract Introduction Medication persistence has rarely been studied for integrase strand transfer inhibitor (INSTI)-based regimens among patients living HIV (PLWH) in Asia. This study investigated medication persistence for newly prescribed INSTI-based...
by evivier@statinmed.com | Aug 16, 2022 | Cardiovascular, Publication
Abstract Background Oral anticoagulants (OACs) mitigate stroke risk in patients with atrial fibrillation (AF). The study aim was to analyze prevalence and predictors of OAC underutilization. Methods Newly diagnosed AF patients with a CHA2DS2-VASc score ≥ 2 were...
by evivier@statinmed.com | Jul 23, 2022 | Cardiovascular, Publication, Pulmonary
Abstract BACKGROUND: Pulmonary arterial hypertension (PAH) is a rare, progressive, and fatal disease associated with considerable overall clinical and economic burden. Although the direct health care costs of PAH have been well described, there are few data...
by evivier@statinmed.com | Jun 7, 2022 | Mental Health, Publication
Abstract Objective: Although a high incidence of major depressive disorder (MDD) and an increased risk of suicide are observed among the veteran population, there are yet limited real-world data characterizing patients with MDD with acute suicidal...
